Enveric Biosciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ENVB research report →
About the company
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress.
- CEO
- Joseph Edward Tucker
- IPO
- 2015
- Employees
- 5
- HQ
- Naples, FL, US
Price Chart
- Market Cap
- $865.67K
- P/E
- -0.05
- P/S
- 0.00
- P/B
- 0.43
- EV/EBITDA
- 0.50
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -220.99%
- ROIC
- -162.43%
- Revenue
- $0 · 0.00%
- Net Income
- $-12,131,472 · -26.70%
- EPS
- $-36.24 · 84.14%
- Op Income
- $-8,774,448
- FCF YoY
- -5.38%
- 52W High
- $17.64
- 52W Low
- $1.26
- 50D MA
- $2.41
- 200D MA
- $4.10
- Beta
- 1.10
- Avg Volume
- 3.92M
Get TickerSpark's AI analysis on ENVB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 23, 25 | DeWitt Sheila | other | 7,633 |
| Dec 23, 25 | Kegler George A. | other | 7,633 |
| Dec 23, 25 | PASQUALONE FRANK | other | 7,633 |
| Dec 23, 25 | Schabacker Marcus | other | 7,633 |
| Dec 23, 25 | Tucker Joseph Edward | other | 60,296 |
| Dec 23, 25 | WEBB MICHAEL D | other | 7,633 |
| Dec 23, 25 | Coveney Kevin Michael | other | 40,198 |
| May 8, 25 | Coveney Kevin Michael | other | 74,150 |
| May 8, 25 | Facchini Peter J. | other | 24,717 |
| May 8, 25 | Tucker Joseph Edward | other | 98,866 |
Our ENVB coverage
Recent articles, reports, and earnings notes.
No research on ENVB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ENVB report →Similar companies
Peers in the same neighborhood.